JIANGSU LIANHUAN PHARMACEUTICAL CO., LTD.

News Jiangsu Lianhuan Pharmaceutical Co., Ltd.

Equities

600513

CNE000001DP6

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-06-25 EDT			5-day change	1st Jan Change
8.21 ^CNY	+3.01%		0.00%	-26.30%

08:47am	Lianhuan Pharmaceutical's Moxifloxacin Hydrochloride Tablets Get Drug Registration Certificate	MT
06-20	China Grants Active Pharmaceutical Ingredient Marketing Approval for Lianhuan Pharma's Cardiac Treatment	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Lianhuan Pharmaceutical's Moxifloxacin Hydrochloride Tablets Get Drug Registration Certificate	02:47am	MT
China Grants Active Pharmaceutical Ingredient Marketing Approval for Lianhuan Pharma's Cardiac Treatment	06-20	MT
China Approves Lianhuan Pharma's Prostate Cancer Tablets	06-05	MT
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Lianhuan Pharma Obtains China Registration Approval for Antihistamine	04-09	MT
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-05	CI
Lianhuan Pharma's Production Lines Pass GMP Inspection	11-07	MT
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Jiangsu Lianhuan Pharma Passes GMP Compliance Inspection	23-10-19	MT
MFM KOREA Co., Ltd. announced that it expects to receive KRW 23.99999924 billion in funding from Jiangsu Lianhuan Pharmaceutical Co., Ltd. and other investors	23-10-05	CI
Jiangsu Lianhuan Pharma Gets Nod to Market Ingredient For Drug Against Addison’s Disease	23-09-15	MT
Jiangsu Lianhuan Pharma Plans Listing Unit on ‘New Third Board’	23-09-12	MT
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Foyou Pharma Passes Drug GMP Compliance Inspection	23-06-14	MT
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Jiangsu Lianhuan Pharma to Raise 450 Million Yuan From Bond Sale	23-03-09	MT
Lianhuan Pharma Gets Nod for Erectile Dysfunction Drug	23-03-06	MT
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-02	CI
Jiangsu Lianhuan Pharmaceutical Gets Nod to Market Antihistamine Ingredient in China	23-02-10	MT
Lianhuan Pharma Gets Nod for Anti-Allergy Drug Registration	23-01-09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Jiangsu Lianhuan Pharmaceutical Co., Ltd.

Equities

600513

CNE000001DP6

Summary

Filters